ADXN Financials
Addex Therapeutics Ltd - Financial statements & key metrics
Stock Price
$7.17
Market Cap
$8.83M
EPS
$-9.40
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$404102.00
Gross Profit
$404102.00
Operating Income
$-2.76M
Net Income
$7.06M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$10.68M
Total Liabilities
$1.00M
Shareholders Equity
$9.68M
Cash & Equivalents
$3.34M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-5.37M
CapEx
$1273
Free Cash Flow
$-5.37M
Profitability Metrics
Gross Margin
-331.6%
Operating Margin
-14.0%
ROE
-0.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ADXN revenue?
ADXN's most recent quarterly revenue was $404102.00. Annual revenue can be calculated by summing the four most recent quarters.
Is ADXN profitable?
ADXN reported a profit of $7.06M in the most recent quarter.
What is ADXN market cap?
ADXN has a market capitalization of $8.83M, making it a small-cap stock.
Does ADXN have debt?
View ADXN's balance sheet for debt information.
What is ADXN cash flow?
ADXN's most recent quarterly free cash flow was $-5.37M.